carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule [Crexont]
RxNorm concept 2690281, branded drug (sbd). Prescribable name: CREXONT 52.5 MG / 210 MG Extended Release Oral Capsule.
- RxCUI
- 2690281
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2690281 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Crexont (carbidopa 52.5 MG / levodopa 210 MG) Extended Release Oral Capsule; carbidopa 52.5 MG / L-DOPA 210 MG Extended Release Oral Capsule [Crexont]
Related concepts
- carbidopa 52.5 MG (SCDC, consists of)
- levodopa 210 MG (SCDC, consists of)
- carbidopa 52.5 MG / levodopa 210 MG [Crexont] (SBDC, consists of)
- Extended Release Oral Capsule (DF, has dose form)
- Crexont (BN, has ingredient)
- carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2690281 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2690281 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2690281. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.